AOD-9604 (Anti-Obesity Drug)

Promotes lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) in adipose tissue, supporting targeted fat reduction without significant impact on IGF-1 (Insulin-like Growth Factor 1) or appetite.

A synthetic fragment of human growth hormone (hGH) corresponding to the C-terminal region (residues 177-191) that stimulates fat metabolism via pathways including beta-3 adrenergic signalling, while avoiding full hGH effects.

Strength: 5 mg/mL
Volume: 3 mL
Dosage Form: Subcutaneous injection (disposable)

Note: All products available through the CeleRevive platform are of high purity and are sourced from GMP-compliant manufacturing facilities. All injectables are >98-99% purity. Products are imported and distributed by fully licensed wholesale pharmacies, compounded and dispensed by fully licensed, compliant compounding pharmacies, and supplied only upon prescription by our licensed medical practitioner.

Regulatory Status: AOD-9604 is classified as an Investigational / Experimental Product in South Africa. It is not registered by SAHPRA for the indications described and is supplied on a patient-specific basis via prescription from a licensed medical practitioner through licensed compounding pharmacies as an experimental or off-label product.